Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (AVERT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Mayo Clinic
Comprehensive Cancer Center of Wake Forest University
Norris Cotton Cancer Center
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Steven Ades, University of Vermont
ClinicalTrials.gov Identifier:
NCT00970905
First received: August 25, 2009
Last updated: December 27, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)